Medicare Enrolled

Dr. David Alboukrek, MD

Rheumatology · Delray Beach, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
5162 LINTON BLVD, Delray Beach, FL 33484
5614981114
In practice since 2006 (19 years)
NPI: 1255434031 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Alboukrek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alboukrek? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Alboukrek

Dr. David Alboukrek is a rheumatology in Delray Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Alboukrek performed 88,567 Medicare services across 7,403 unique beneficiaries.

Between the years covered by Open Payments, Dr. Alboukrek received a total of $9,858 from 39 pharmaceutical and/or device companies across 547 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Alboukrek is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 27% volume in FL$ $9,858 industry payments

Medicare Practice Summary

Medicare Utilization ↗
88,567
Medicare services
Top 27% in FL for rheumatology
7,403
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,661 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)25,440$18$25
Romosozumab injection (Evenity) for osteoporosis22,890$8$15
Certolizumab injection (Cimzia)18,800$4$10
Golimumab infusion (Simponi Aria)7,450$11$32
Abatacept infusion (Orencia)3,200$34$60
Blood draw (venipuncture)1,265$8$10
Office visit, established patient (30-39 min)1,176$97$271
Calcium level, total915$5$12
Office visit, established patient (20-29 min)794$70$191
Vitamin D level test784$29$73
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle784$59$145
Complete blood count (CBC) with differential630$8$19
Blood creatinine level629$5$11
Urea nitrogen level to assess kidney function, quantitative622$4$10
Red blood cell sedimentation rate, to detect inflammation, non-automated349$4$9
Liver function blood test panel303$8$20
Phosphate level test278$5$10
C-reactive protein test (inflammation marker)278$5$13
Phosphatase (enzyme) measurement, alkaline, isoenzymes277$14$30
Blood sodium level203$5$10
Blood glucose (sugar) level202$4$10
Blood potassium level202$5$10
New patient office visit (45-59 min)197$128$354
Administration of chemotherapy into vein, 1 hour or less113$99$205
Bone density scan (DEXA)107$39$79
Parathyroid hormone level test84$40$102
Injection, zoledronic acid, 1 mg75$6$45
Thyroid stimulating hormone (TSH) test69$16$42
Uric acid level test59$4$11
Injection, methylprednisolone acetate, 40 mg45$6$12
Screening test for autoimmune disorder40$12$30
Measurement of antibody for assessment of autoimmune disorder, any method40$18$89
Rheumatoid factor analysis38$6$14
Joint injection, major joint34$54$139
X-ray of knee, 1-2 views31$28$71
Creatine kinase (cardiac enzyme) level, total29$6$16
Screening test for antibody to noninfectious agent27$12$29
New patient office visit, complex (60-74 min)27$165$468
Analysis of substance using immunoassay technique, multiple step method19$11$28
Shoulder X-ray, 2+ views17$28$71
Injection into tendon or ligament16$46$120
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less15$50$105
Hip X-ray, 2-3 views14$36$96
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.0% high complexity
77.0% medium
11.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$9,858
Total received (2018-2024)
Avg $1,408/year across 7 years
Top 43% in FL for rheumatology
39
Companies
547
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,725 (98.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$132 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,633
2023
$1,500
2022
$1,734
2021
$1,055
2020
$358
2019
$1,804
2018
$1,773

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$1,412
Amgen Inc.
$1,221
AbbVie Inc.
$844
Novartis Pharmaceuticals Corporation
$684
E.R. Squibb & Sons, L.L.C.
$677
ABBVIE INC.
$669
PFIZER INC.
$634
AbbVie, Inc.
$434
UCB, Inc.
$374
GlaxoSmithKline, LLC.
$368
Radius Health, Inc.
$353
Horizon Therapeutics plc
$259
Genentech USA, Inc.
$192
Boehringer Ingelheim Pharmaceuticals, Inc.
$171
Alvogen Inc
$145
Mallinckrodt Hospital Products Inc.
$138
SANOFI-AVENTIS U.S. LLC
$132
Mallinckrodt Enterprises LLC
$119
Kiniksa Pharmaceuticals International, plc
$116
AstraZeneca Pharmaceuticals LP
$115
Lilly USA, LLC
$88
Horizon Pharma plc
$83
Mallinckrodt LLC
$81
Celgene Corporation
$64
SOBI, INC
$60
Sobi, Inc
$48
Merck Sharp & Dohme Corporation
$47
Takeda Pharmaceuticals U.S.A., Inc.
$46
Fresenius Kabi USA, LLC
$39
Actelion Pharmaceuticals US, Inc.
$39
Ferring Pharmaceuticals Inc.
$38
ANI Pharmaceuticals, Inc.
$34
West-Ward Pharmaceuticals
$33
Alexion Pharmaceuticals, Inc.
$26
Aurinia Pharma U.S., Inc.
$21
Organon LLC
$19
Cumberland Pharmaceuticals, Inc.
$16
GENZYME CORPORATION
$14
Organon Llc
$7
Top 3 companies account for 35.3% of total payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Arcalyst · BENLYSTA · COSENTYX · CYLTEZO · Cimzia · EUFLEXXA · EVENITY · Enbrel · FORTEO · HADLIMA · HUMIRA · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · OFEV · OPSUMIT · ORENCIA · Otezla · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REDITREX · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SILTEX Breast Implants · SIMPONI ARIA · SKYRIZI · STELARA · Strensiq · TALTZ · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · Uloric · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $11 per 100 Medicare services performed
Looking for a rheumatology in Delray Beach?
Compare rheumatologys in the Delray Beach area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
58
Per 100K population
3.8
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Alboukrek is a mixed practice specialist, with above-average Medicare volume (top 27% in FL), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Alboukrek experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Alboukrek performed 25,440 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alboukrek receive payments from pharmaceutical companies?
Yes. Dr. Alboukrek received a total of $9,858 from 39 companies across 547 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alboukrek's costs compare to other rheumatologys in Delray Beach?
Dr. Alboukrek's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alboukrek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →